• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表现为内界膜下出血的2型黄斑毛细血管扩张症。

Macular telangiectasia type 2 presenting with sub-internal limiting membrane hemorrhage.

作者信息

Ramamurthy Srishti Raksheeth, Dave Vivek Pravin

机构信息

Standard Chartered-LVPEI Academy for Eye Care Education, LV Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, Telangana, India.

Anant Bajaj Retina Institute, LV Prasad Eye Institute, Kallan Anji Reddy Campus, Hyderabad, Telangana, India.

出版信息

Taiwan J Ophthalmol. 2023 Jul 18;15(3):491-493. doi: 10.4103/tjo.TJO-D-23-00033. eCollection 2025 Jul-Sep.

DOI:10.4103/tjo.TJO-D-23-00033
PMID:40995325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12456921/
Abstract

A 60-year-old female with recent-onset defective vision in her right eye (RE) was found to have presenting visual acuity of 20/320 with a sub-internal limiting membrane hemorrhage at the macula, which was cleared surgically. Postoperatively, visual acuity improved significantly to 20/30. Multimodal imaging revealed the characteristic features of macular telangiectasia (MacTel) type 2 in both eyes. Worsening of vision in the RE occurred at 1-year follow-up. Optical coherence tomography angiography revealed a network of subretinal new vessels in the RE, which was treated with intravitreal Avastin injection. A stable clinical course in both eyes was noted during subsequent follow-ups. A rare presentation of preretinal hemorrhage in the absence of a choroidal neovascular membrane as the first sign of MacTel type 2 was managed satisfactorily with surgical intervention.

摘要

一名60岁女性近期右眼视力出现问题,初诊时视力为20/320,黄斑区存在内界膜下出血,通过手术清除了出血。术后,视力显著提高至20/30。多模态成像显示双眼均有2型黄斑毛细血管扩张症(MacTel)的特征性表现。在1年随访时,右眼视力恶化。光学相干断层扫描血管造影显示右眼有视网膜下新生血管网络,通过玻璃体腔内注射阿瓦斯汀进行了治疗。在随后的随访中,双眼病情保持稳定。2型MacTel以视网膜前出血而非脉络膜新生血管膜为首发症状的罕见表现,通过手术干预得到了满意的处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262b/12456921/d0bb750091eb/TJO-15-491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262b/12456921/c00716c5123b/TJO-15-491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262b/12456921/9f2e84783558/TJO-15-491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262b/12456921/d0bb750091eb/TJO-15-491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262b/12456921/c00716c5123b/TJO-15-491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262b/12456921/9f2e84783558/TJO-15-491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262b/12456921/d0bb750091eb/TJO-15-491-g003.jpg

相似文献

1
Macular telangiectasia type 2 presenting with sub-internal limiting membrane hemorrhage.表现为内界膜下出血的2型黄斑毛细血管扩张症。
Taiwan J Ophthalmol. 2023 Jul 18;15(3):491-493. doi: 10.4103/tjo.TJO-D-23-00033. eCollection 2025 Jul-Sep.
2
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
3
Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH).玻璃体切除术联合内界膜(ILM)剥除术与单纯玻璃体切除术治疗特发性全层黄斑裂孔(FTMH)的对比
Cochrane Database Syst Rev. 2013 Jun 5(6):CD009306. doi: 10.1002/14651858.CD009306.pub2.
4
Ocriplasmin for symptomatic vitreomacular adhesion.用于有症状性玻璃体黄斑粘连的奥克纤溶酶
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD011874. doi: 10.1002/14651858.CD011874.pub2.
5
Vitrectomy for idiopathic macular hole.特发性黄斑裂孔玻璃体切除术
Cochrane Database Syst Rev. 2015 May 12;2015(5):CD009080. doi: 10.1002/14651858.CD009080.pub2.
6
Comparable choroidal thickness between treated eyes and untreated fellow-eyes in patients with unilateral neovascular AMD: a paired-eyes comparative study.单侧新生血管性年龄相关性黄斑变性患者治疗眼与未治疗对侧眼脉络膜厚度的比较:配对眼比较研究。
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 8. doi: 10.1007/s00417-025-06751-7.
7
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.用于保护黄斑健康的蓝光滤过型人工晶状体
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
8
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.抗血管内皮生长因子联合玻璃体内注射类固醇治疗糖尿病性黄斑水肿。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD011599. doi: 10.1002/14651858.CD011599.pub2.
9
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
10
Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications.2型黄斑毛细血管扩张症:长期疾病进展及并发症管理
Turk J Ophthalmol. 2025 Aug 21;55(4):193-199. doi: 10.4274/tjo.galenos.2025.19940.

本文引用的文献

1
The Diagnosis and Management of Macular Telangiectasia.
Ophthalmic Surg Lasers Imaging Retina. 2019 Mar 1;50(3):139-144. doi: 10.3928/23258160-20190301-02.
2
Preretinal hemorrhage as a presenting sign of idiopathic macular telangiectasia type 2.视网膜前出血作为2型特发性黄斑毛细血管扩张症的首发体征。
Clin Ophthalmol. 2015 Aug 10;9:1417-20. doi: 10.2147/OPTH.S83335. eCollection 2015.
3
Macular telangiectasia type 2.2 型黄斑毛细血管扩张症。
Prog Retin Eye Res. 2013 May;34:49-77. doi: 10.1016/j.preteyeres.2012.11.002. Epub 2012 Dec 3.
4
Idiopathic macular telangiectasia.特发性黄斑毛细血管扩张症
Arch Ophthalmol. 2006 Apr;124(4):450-60. doi: 10.1001/archopht.124.4.450.